Extended-spectrum β-lactamase-mediated third-generation cephalosporin resistance in Shigella isolates in Bangladesh [3]

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 4, 2004, Pages 846-847

  Rahman, Mahbubur ^a   Shoma, Shereen ^a   Rashid, Harunur ^a   Siddique, A K ^a   Nair, G B ^a   Sack, D A ^a  

^a ICDDR B Centre for Health and Population Research   (Bangladesh)

Author keywords

Ceftriaxone; ESBLs; Multidrug resistance; Shigellosis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFIXIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; MECILLINAM; NALIDIXIC ACID; PIVMECILLINAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BANGLADESH; COMMUNICABLE DISEASE; HUMAN; LETTER; MULTIDRUG RESISTANCE; NONHUMAN; PATHOGENESIS; PLASMID; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; SPECIES DIFFERENCE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; HUMANS; SHIGELLA;

EID: 6344282912     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh413     Document Type: Letter

References (6)

1. Sack, R. B., Rahman, M., Yunus, M. et al. (1997). Antimicrobial resistance in organisms causing diarrheal diseases. Clinical Infectious Diseases 24, Suppl. 1, S102-5.
2. Varsano, I., Elditz-Marcus, T., Nussinotich, M. et al. (1991). Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children. Journal of Pediatrics 118, 627-32.
3. Bradford, P. A. (2001). Extended-spectrum β-lactamases in the 21st century: characterisation, epidemiology and detection of this important resistant threat. Clinical Microbiology Reviews 14, 933-51.
4. Ahmed, J. & Kundu, M. (1999). Molecular characterization of the SHV-11 β-lactamase of Shigella dysenteriae. Antimicrobial Agents and Chemotherapy 43, 2081-3.
5. Ziya, C. A., Zeynep, G., Meral, B. et al. (2003). CTX-M-3 extended-spectrum β-lactamase in a Shigella sonnei clinical isolate: first report from Turkey. Scandinavian Journal of Infectious Diseases 35, 503-5.
6. Bhattacharya, S. K., Sarkar, K., Nair, G. B. et al. (2003). Multidrug-resistant Shigella dysenteriae type 1 in south Asia. Lancet Infectious Diseases 3, 755.